These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1525212)

  • 1. Immunotherapy of malignancy by in vivo gene transfer into tumors.
    Hum Gene Ther; 1992 Aug; 3(4):399-410. PubMed ID: 1525212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions.
    Rini BI; Selk LM; Vogelzang NJ
    Clin Cancer Res; 1999 Oct; 5(10):2766-72. PubMed ID: 10537340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.
    Rubin J; Galanis E; Pitot HC; Richardson RL; Burch PA; Charboneau JW; Reading CC; Lewis BD; Stahl S; Akporiaye ET; Harris DT
    Gene Ther; 1997 May; 4(5):419-25. PubMed ID: 9274718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to the points to consider for immunotherapy of malignancy by in vivo gene transfer into tumors.
    Hum Gene Ther; 1992 Dec; 3(6):705-11. PubMed ID: 1482710
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.
    Nabel GJ; Nabel EG; Yang ZY; Fox BA; Plautz GE; Gao X; Huang L; Shu S; Gordon D; Chang AE
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11307-11. PubMed ID: 8248244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes.
    Nabel GJ; Gordon D; Bishop DK; Nickoloff BJ; Yang ZY; Aruga A; Cameron MJ; Nabel EG; Chang AE
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15388-93. PubMed ID: 8986821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct gene transfer for treatment of human cancer.
    Nabel GJ; Yang ZY; Nabel EG; Bishop K; Marquet M; Felgner PL; Gordon D; Chang AE
    Ann N Y Acad Sci; 1995 Nov; 772():227-31. PubMed ID: 8546397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for head and neck cancer.
    Gleich LL
    Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
    Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
    Salamone FN; Gleich LL; Li YQ; Stambrook PJ
    Laryngoscope; 2004 Apr; 114(4):612-5. PubMed ID: 15064612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
    Foley R; Tozer R; Wan Y
    Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
    Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
    J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for cancer by direct gene transfer into tumors.
    Nabel GJ; Chang AE; Nabel EG; Plautz GE; Ensminger W; Fox BA; Felgner P; Shu S; Cho K
    Hum Gene Ther; 1994 Jan; 5(1):57-77. PubMed ID: 8155772
    [No Abstract]   [Full Text] [Related]  

  • 16. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
    Xiang J; Chen Y; Moyana T
    Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
    Stopeck AT; Hersh EM; Akporiaye ET; Harris DT; Grogan T; Unger E; Warneke J; Schluter SF; Stahl S
    J Clin Oncol; 1997 Jan; 15(1):341-9. PubMed ID: 8996161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer.
    Albertini MR; Emler CA; Schell K; Tans KJ; King DM; Sheehy MJ
    Cancer Gene Ther; 1996; 3(3):192-201. PubMed ID: 8725884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategies for gene therapy of melanoma].
    Dummer R; Davis-Daneshfar A; Döhring C; Döbbeling U; Burg G
    Hautarzt; 1995 May; 46(5):305-8. PubMed ID: 7607892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy.
    del Campo AB; Aptsiauri N; Méndez R; Zinchenko S; Vales A; Paschen A; Ward S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F
    Scand J Immunol; 2009 Aug; 70(2):125-35. PubMed ID: 19630918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.